Evidence map›Paper›PMID 40369386›Full record

ArticleMolecular imaging and biology2025

Integrative Analysis of

Mai Kim, Wenchao Gu, Reika Kawabata- Iwakawa, Shinichiro Kina, Takahito Nakajima, Tetsuya Higuchi, Masaru Ogawa, Keisuke Suzuki, Yoshito Tsushima, Satoshi Yokoo

Abstract read
In one paragraph

Article in Molecular imaging and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mai KimDepartment of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan.
Wenchao GuDepartment of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan. sunferrero@gmail.com.ORCID http://orcid.org/0000-0002-1505-9887
Reika Kawabata- IwakawaDivision of Integrated Oncology Research, Gunma University Initiative for Advanced Research (GIAR), Gunma University, Maebashi, Japan.
Shinichiro KinaDivision of Integrated Oncology Research, Gunma University Initiative for Advanced Research (GIAR), Gunma University, Maebashi, Japan.
Takahito NakajimaDepartment of Diagnostic and Interventional Radiology, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Tetsuya HiguchiDepartment of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
Masaru OgawaDepartment of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan.
Keisuke SuzukiDepartment of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan.
Yoshito TsushimaDepartment of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
Satoshi YokooDepartment of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan.

Funding

Japan Society for the Promotion of Science 18K1702Japan Society for the Promotion of Science 21K09838Japan Society for the Promotion of Science 22K20814Japan Society for the Promotion of Science 24K18786
6 · The paper itself

Abstract

backgroundThis study explored the relationship between mRNA expression profiles obtained through next-generation sequencing (NGS) and

resultsThe gene ankyrin repeat and SOCS box containing two (ASB2) was significantly overexpressed in non-responders and strongly correlated with specific PET radiomic features, including GLRLM_GLNU, GLRLM_RLNU, and GLZLM_GLNU (p < 0.05). High ASB2 expression was also associated with poor prognosis in OSCC patients (p < 0.05) and decreased overall survival, as shown by Kaplan-Meier analysis of the TCGA database (p = 0.017).

conclusionsIntegrating ASB2 expression data with

Indexed as

Carcinoma, Squamous CellFluorodeoxyglucose F18Mouth NeoplasmsNeoplasm Recurrence, LocalPositron-Emission TomographyRNA, MessengerAdultAgedCross-Sectional StudiesFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedNeoplasm MetastasisRadiomicsFluorodeoxyglucose F18RNA, Messenger18F-FDG PETNext-generation sequencingOral squamous cell carcinomaTexture analysis

Identifiers

PMID40369386
PMCPMC12162752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.